Interview: Mohammad Afshar – CEO, Ariana Pharma, France
Mohammad Afshar, CEO of Ariana Pharma, shares his insights on the importance of decision support tools, big data’s impact on the healthcare industry, and the need to translate this data…
Address: 14 ave Duquesne, 75007 Paris,France
Tel: 01 40 56 60 65
Web: http://www.sante.gouv.fr/
The Committee Economic Health Products (CEPS) replaced the previous Economic Committee of drugs in 2000. Its missions have been extended to cover health products and services associated with refundable in addition to drugs and it has been amended accordingly.
CEPS contributes to the development of drug policy by putting into practice advice it receives from relevant ministers, applying it notably to price fixing with respect to expenditure and financial regulation of the market. In order to carry this out, the CEPS reaches agreements with businesses on relevant topics, such as drug prices, price evolution, drug reimbursements, regulations concerning the proper use of drugs and sales volumes, as well as methods of participation of enterprises in the implementation of departmental policies.
Mohammad Afshar, CEO of Ariana Pharma, shares his insights on the importance of decision support tools, big data’s impact on the healthcare industry, and the need to translate this data…
Third generation family member Laure Brenas Baudry explains how CSP has become France’s leading distributor for pharmaceuticals, and how they provide value added services to their large set of clients…
Matthieu Brand, who has been heading the French affiliate of World Courier, AmerisourceBergen for 2.5 years now, shares with great passion the bright future lying ahead of the company in…
Stephane Baudry not only provides insight into his holding company EHDH (European Health Care Distribution Holding), the spectacular growth of affiliate EuroTransPharma and the developments underway for his other subsidiaries…
ResMed MD, Lucile Blaise, explains the medical device company’s focus on delivering data informatics and analytics to patients with sleep-related diseases and disorders in the comfort of their own homes.…
Biotest France’s Olivier Samama discusses their recent re-entry into France, their focus on homecare treatment, and their expertise in fractionation and plasma derived products. What are the objectives and goals…
Sébastien Lucot, General Manager of Uriage, explains the company’s product base, their line of thermal water based products and the healing properties of Uriage water from the French Alps. Lucot…
The GM of France for Bristol-Myers Squibb (BMS) discusses becoming a “diversified biopharma company”, their commitment to remaining a model of excellence for other affiliates, and his personal philosophy of…
Roland Berger’s Patrick Biecheler discusses the French healthcare system, their role in offering specialized consultancy services to the pharmaceutical sector, and the digitalization of the healthcare industry. Can you please…
A physician sending off a quick update to a patient via smartphone; a medical caretaker receiving an alert message that a patient’s medical device requires immediate attention. These are no…
While assessing patient perspectives in comprehensive drug and treatment analyses may sound like a contemporary issue, the Mapi Group has been a pioneer in the practice for over forty years.…
Lyonbiopole was established in 2005 as a cluster designed to support the local business community focused on infectious diseases and microbiology. Philippe Archinard, the Biopole’s president, traces the evolution of…
See our Cookie Privacy Policy Here